Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward C Jones-López

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|July 16, 2015
Quantity and Quality of Inhaled Dose Predicts Immunopathology in TuberculosisKevin P Fennelly, Edward C Jones-López
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2005
Tuberculosis infection among HCWsEdward C Jones-López, Jerrold J Ellner
Frontiers in Immunology|October 21, 2015
Corrigendum: Quantity and Quality of Inhaled Dose Predicts Immunopathology in TuberculosisKevin P Fennelly, Edward C Jones-López
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 18, 2023
Aerosol Sampling Outperforms Sputum to Predict Mycobacterium tuberculosis TransmissionCarlos Acuña-Villaorduña, Kevin P Fennelly, Edward C Jones-López
The Lancet. Infectious Diseases|June 30, 2016
Tuberculosis transmission: sputum vs aerosolsCarlos Acuña-Villaorduña, Laura F White, Kevin P Fennelly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2024
Optimal timing to discontinue respiratory isolation among patients with pulmonary TBCarlos Acuña-Villaorduña, Edward C Jones-López, Grant Theron, et al.
The Lancet. Infectious Diseases|October 25, 2020
Clinical variables and gene signatures in tuberculosisCarlos Acuña-Villaorduña, Edward C Jones-López, Padmini Salgame, et al.
The American Journal of Tropical Medicine and Hygiene|January 13, 2006
Delayed-type hypersensitivity skin test reactivity and survival in HIV-infected patients in Uganda: should anergy be a criterion to start antiretroviral therapy in low-income countries?Edward C Jones-López, Alphonse Okwera, Harriet Mayanja-Kizza, et al.
JAAD Case Reports|December 25, 2025
Dual immunomodulator therapy with upadacitinib and bimekizumab in severe hidradenitis suppurativa: A case reportKenan Kherallah, Claire S Chung, Justin Gillenwater, et al.
American Journal of Epidemiology|May 28, 2020
Using Cure Models to Estimate the Serial Interval of Tuberculosis With Limited Follow-upYicheng Ma, Helen E Jenkins, Paola Sebastiani, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|July 16, 2015
Quantity and Quality of Inhaled Dose Predicts Immunopathology in TuberculosisKevin P Fennelly, Edward C Jones-López
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2005
Tuberculosis infection among HCWsEdward C Jones-López, Jerrold J Ellner
Frontiers in Immunology|October 21, 2015
Corrigendum: Quantity and Quality of Inhaled Dose Predicts Immunopathology in TuberculosisKevin P Fennelly, Edward C Jones-López
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 18, 2023
Aerosol Sampling Outperforms Sputum to Predict Mycobacterium tuberculosis TransmissionCarlos Acuña-Villaorduña, Kevin P Fennelly, Edward C Jones-López
The Lancet. Infectious Diseases|June 30, 2016
Tuberculosis transmission: sputum vs aerosolsCarlos Acuña-Villaorduña, Laura F White, Kevin P Fennelly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2024
Optimal timing to discontinue respiratory isolation among patients with pulmonary TBCarlos Acuña-Villaorduña, Edward C Jones-López, Grant Theron, et al.
The Lancet. Infectious Diseases|October 25, 2020
Clinical variables and gene signatures in tuberculosisCarlos Acuña-Villaorduña, Edward C Jones-López, Padmini Salgame, et al.
The American Journal of Tropical Medicine and Hygiene|January 13, 2006
Delayed-type hypersensitivity skin test reactivity and survival in HIV-infected patients in Uganda: should anergy be a criterion to start antiretroviral therapy in low-income countries?Edward C Jones-López, Alphonse Okwera, Harriet Mayanja-Kizza, et al.
JAAD Case Reports|December 25, 2025
Dual immunomodulator therapy with upadacitinib and bimekizumab in severe hidradenitis suppurativa: A case reportKenan Kherallah, Claire S Chung, Justin Gillenwater, et al.
American Journal of Epidemiology|May 28, 2020
Using Cure Models to Estimate the Serial Interval of Tuberculosis With Limited Follow-upYicheng Ma, Helen E Jenkins, Paola Sebastiani, et al.
Pageof 5